Massachusetts Board of Registration in Pharmacy · Massachusetts
Massachusetts Pharmacy Advertising and Marketing Standards
Massachusetts pharmacy marketing must not misrepresent compounded drugs as FDA-approved, mislead on drug prices or efficacy, or offer copay waivers and coupons to federal health program beneficiaries.
What is Massachusetts Pharmacy Advertising and Marketing Standards?
Massachusetts pharmacy marketing must not misrepresent compounded drugs as FDA-approved, mislead on drug prices or efficacy, or offer copay waivers and coupons to federal health program beneficiaries. Use on Massachusetts pharmacy ads that make drug, compounding, price, coupon or copay claims.
Massachusetts pharmacy marketing must not misrepresent compounded drugs as FDA-approved, mislead on drug prices or efficacy, or offer copay waivers and coupons to federal health program beneficiaries.
How can marketing teams comply?
Use on Massachusetts pharmacy ads that make drug, compounding, price, coupon or copay claims.
What is Massachusetts Pharmacy Advertising and Marketing Standards?
Massachusetts pharmacy marketing must not misrepresent compounded drugs as FDA-approved, mislead on drug prices or efficacy, or offer copay waivers and coupons to federal health program beneficiaries.
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Louisiana's medical cannabis program (Louisiana Department of Health — Medical Marijuana Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.